226 related articles for article (PubMed ID: 9250079)
1. Establishing a cancer risk evaluation program.
Calzone KA; Stopfer J; Blackwood A; Weber BL
Cancer Pract; 1997; 5(4):228-33. PubMed ID: 9250079
[TBL] [Abstract][Full Text] [Related]
2. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
3. Organizing cancer genetics programs: the Swiss model.
Pichert G; Stahel RA
J Clin Oncol; 2000 Nov; 18(21 Suppl):65S-9S. PubMed ID: 11060330
[TBL] [Abstract][Full Text] [Related]
4. Genetic predisposition testing: clinical implications for oncology nurses.
Calzone KA
Oncol Nurs Forum; 1997 May; 24(4):712-8. PubMed ID: 9159785
[TBL] [Abstract][Full Text] [Related]
5. The genetic testing of children for cancer susceptibility: ethical, legal, and social issues.
Patenaude AF
Behav Sci Law; 1996; 14(4):393-410. PubMed ID: 9156420
[TBL] [Abstract][Full Text] [Related]
6. Ethical and scientific considerations for chemoprevention research in cohorts at genetic risk for breast cancer.
Nayfield SG
J Cell Biochem Suppl; 1996; 25():123-30. PubMed ID: 9027608
[TBL] [Abstract][Full Text] [Related]
7. Interest, awareness, and perceptions of genetic testing among Hispanic family members of breast cancer survivors.
Ramirez AG; Aparicio-Ting FE; de Majors SS; Miller AR
Ethn Dis; 2006; 16(2):398-403. PubMed ID: 17682241
[TBL] [Abstract][Full Text] [Related]
8. Cancer genetic counseling in public health care hospitals: the experience of three Brazilian services.
Palmero EI; Kalakun L; Schüler-Faccini L; Giugliani R; Regla Vargas F; Rocha JC; Ashton-Prolla P
Community Genet; 2007; 10(2):110-9. PubMed ID: 17380061
[TBL] [Abstract][Full Text] [Related]
9. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
[TBL] [Abstract][Full Text] [Related]
10. Development of the breast cancer education and risk assessment program.
Snyder LA; Soballe DB; Lahl LL; Nehrebecky ME; Soballe PW; Klein PM
Oncol Nurs Forum; 2003; 30(5):803-8. PubMed ID: 12949593
[TBL] [Abstract][Full Text] [Related]
11. Hereditary breast-ovarian cancer: clinical findings and medical management.
Marshall M; Solomon S
Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 genetic mutation and its link to ovarian cancer: implications for advanced practice nurses.
Brunsvold AN; Wung SF; Merkle CJ
J Am Acad Nurse Pract; 2005 Dec; 17(12):518-26. PubMed ID: 16293160
[TBL] [Abstract][Full Text] [Related]
13. Psychosocial impact of the lack of information given at referral about familial risk for cancer.
Metcalfe A; Werrett J; Burgess L; Clifford C
Psychooncology; 2007 May; 16(5):458-65. PubMed ID: 16933207
[TBL] [Abstract][Full Text] [Related]
14. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
[TBL] [Abstract][Full Text] [Related]
15. [Genetic counselling in monogenic cancer syndromes].
Brøndum-Nielsen K; Gerdes AM
Ugeskr Laeger; 2006 Jun; 168(24):2350-4. PubMed ID: 16822419
[TBL] [Abstract][Full Text] [Related]
16. Hereditary breast cancer. Psychosocial issues and family physicians' role.
Carroll JC; Heisey RE; Warner E; Goel V; McCready DR
Can Fam Physician; 1999 Jan; 45():126-32. PubMed ID: 10889865
[TBL] [Abstract][Full Text] [Related]
17. How interested is the public in genetic testing for colon cancer susceptibility? Report of a cross-sectional population survey.
Graham ID; Logan DM; Hughes-Benzie R; Evans WK; Perras H; McAuley LM; Laupacis A; Stern H
Cancer Prev Control; 1998 Aug; 2(4):167-72. PubMed ID: 10093629
[TBL] [Abstract][Full Text] [Related]
18. [Ethical legal and social issues in pre-symptomatic testing for cancer susceptibility in familial tumors].
Tsunematsu Y
Gan To Kagaku Ryoho; 1997 Jun; 24(8):945-50. PubMed ID: 9212802
[TBL] [Abstract][Full Text] [Related]
19. Perceptions of genetic testing for cancer predisposition among Ashkenazi Jewish women.
Lewis MJ; Peterson SK
Community Genet; 2007; 10(2):72-81. PubMed ID: 17380056
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with decisions about clinical BRCA1/2 testing.
Armstrong K; Calzone K; Stopfer J; Fitzgerald G; Coyne J; Weber B
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1251-4. PubMed ID: 11097234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
